James Vardiman to Administration, Oral
This is a "connection" page, showing publications James Vardiman has written about Administration, Oral.
Connection Strength
0.018
-
Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan: a randomized phase 2 trial by the Cancer and Leukemia Group B (CALGB 19803). Cancer. 2009 Jan 01; 115(1):84-93.
Score: 0.018